4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000008
CFO AND TREASURER sold 10,000 shares at an average $577.89 ($5,778,922)
- CFO AND TREASURER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $135.42 | $1,354,200 | 28,876 | D |
| 2026-04-09 | Sale : show line 2 in the form 10b5-1 | −560 | $574.87 | $321,926 | 28,316 | D |
| 2026-04-09 | Sale : show line 3 in the form 10b5-1 | −1,956 | $575.53 | $1,125,731 | 26,360 | D |
| 2026-04-09 | Sale : show line 4 in the form 10b5-1 | −1,586 | $576.63 | $914,530 | 24,774 | D |
| 2026-04-09 | Sale : show line 5 in the form 10b5-1 | −1,617 | $577.77 | $934,247 | 23,157 | D |
| 2026-04-09 | Sale : show line 6 in the form 10b5-1 | −1,139 | $578.52 | $658,939 | 22,018 | D |
| 2026-04-09 | Sale : show line 7 in the form 10b5-1 | −1,224 | $579.75 | $709,613 | 20,794 | D |
| 2026-04-09 | Sale : show line 8 in the form 10b5-1 | −1,756 | $580.64 | $1,019,602 | 19,038 | D |
| 2026-04-09 | Sale : show line 9 in the form 10b5-1 | −162 | $582.30 | $94,333 | 18,876 | D |
| Open-market sales · 10,000 sh · avg $577.89 · $5,778,922 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-09 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −10,000 | 102,500 | D |
Loading xslF345X06/primarydocument.xml…